Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2010
05/19/2010CN101708310A Chinese medicinal preparation for treating neurotica
05/19/2010CN101708287A Chinese medicinal preparation for treating hemiparalysis disease and preparation method thereof
05/19/2010CN101708281A Chinese medicinal preparation for nourishing heart and tranquilizing mind and preparation method thereof
05/19/2010CN101708255A Chinese medicinal composition for treating depression
05/19/2010CN101708250A Medicament for treating cardio-cerebrovascular diseases
05/19/2010CN101708238A Qingkailing syrup and preparation method thereof
05/19/2010CN101708231A Blood pressure and blood fat reducing oral liquid used for improving sleep quality and preparation method thereof
05/19/2010CN101708230A Narcotic-abstaining medicine and preparation method thereof
05/19/2010CN101708217A Traditional Chinese medicine composition for restoring normal coordination between heart and kidney, relieving depressed liver, soothing nerves and treating insomnia and preparation method thereof
05/19/2010CN101708214A Plaster for treating facioplegia and acupuncture point applying method thereof
05/19/2010CN101708164A Rivastigmine slow-release microspheres and preparation method thereof
05/19/2010CN101708163A Selegiline sustained release microspheres and method for preparing same
05/19/2010CN101318931B Diaryl substituted pyrazole derivative, preparation method and application thereof
05/19/2010CN101194982B Antidepressive Chinese medicine composition and method of preparing the same
05/19/2010CN101167786B Process of extracting total flavone from fordia cauliflora Hemsl
05/19/2010CN101152531B Heart-nourishing brain-nourishing traditional Chinese medicine preparation for treating amnesia
05/19/2010CN101129826B Health pillow with Chinese medicine
05/19/2010CN101129733B Formula for treating vascular dementia and method for producing the same
05/19/2010CN101129633B Medicine for neurasthenia and its preparation
05/19/2010CN101129492B Traditional Chinese medicine formulated product for treating melancholia
05/19/2010CN101099828B Soft capsule for reducing blood pressure and improving sleeping
05/19/2010CN101095701B Flaky medicine containing Hirsutella hepiali - cordyceps fungus powder and method for preparing the same
05/19/2010CN101066325B Chinese herbal medicine liniment for treating paralysis
05/19/2010CN101066278B Medicine use of energy mixture
05/19/2010CN101062215B Chinese traditional medicine powder taken orally for treating cancer pain
05/19/2010CN101040894B Preparing and application of Yulangsan extract
05/19/2010CN101029065B Bean-curd pectin analogue and its use in medicine for preventing depression
05/19/2010CN101019980B Health product for improving sleep quality
05/19/2010CN101011171B Dried orange peel aurantium tea beverage and its production method
05/19/2010CN101007055B Preparation method of pollen of eucommia ulmoides soft capsules containing alpha-linolenic acid
05/19/2010CN100998606B Application of senso for preparing traditional Chinese medicine plaster to treat facial neuroparalysis
05/18/2010US7718797 Fasudil-containing preparation and method of improving stability thereof
05/18/2010US7718795 Succinoylamino benzodiazepines as inhibitors of aβ protein production
05/18/2010US7718702 Cannabinoid receptor ligands
05/18/2010US7718698 Adding fatty acid ester, a fatty acid amide, a free fatty acid or a hydrocarbon, to a mixture of a fat or an oil, being edible or for use in cosmetics; stripping and separating the environmental pollutant present in the fat or oil
05/18/2010US7718670 antagonists of M3 muscarinic receptors; N-(1-Azabicyclo[2.2.2]oct-3-yl)-2-hydroxy-2,2-dithien-2-ylacetamide; respiratory disorders, urological disorders, gastrointestinal disorders, cardiovascular disorders; reaction with organometallic derivative
05/18/2010US7718661 E.g., 4-Difluoro-5-[4-trifluoromethyl-2-(4-trifluoromethyl-phenyl)-imidazo[1,5-a]pyrimidin-8-ylethynyl]-benzenesulfonamide; 4-[4-Difluoromethyl-2-(4-trifluoromethyl-phenyl)-imidazo[1,5-a]pyrimidin-8-ylethynyl]-benzenesulfonamide; metabotropic glutamate receptor antagonists; nervous system disorders
05/18/2010US7718654 Substituted pteridines for the treatment of inflammatory diseases
05/18/2010US7718650 Piperazino or diazepino-substituted arylsulfonamides; obesity, type II diabetes and/or central nervous system disorders; 4-chloro-N-[5-(4-methyl-1,4-diazepan-1-yl)-2-nitrophenyl]benzenesulfonamide for example; Serotonin 5-HT6 receptor antagonist activity
05/18/2010US7718649 Physical states of a pharmaceutical drug substance
05/18/2010US7718647 5,6,7,8-Tetrahydro-4H-thieno[2,3-d]azepine and 4,4a,5,6,7,8-hexahydro-3H-1-thia-6-aza-cyclopenta[cd]azulene derivatives can be used to treat addiction, anxiety, depression and obesity
05/18/2010US7718639 7-hydroxyepiandrosterone having neuroprotective activity
05/18/2010US7718606 Methods for treating muscle diseases and disorders
05/18/2010US7718605 conjugated drug comprising nerve growth factor linked to a steroid; for tissue-targeted therapy; treating pain
05/18/2010US7718391 Assays for identifying modulators of rhomboid polypeptides
05/18/2010US7718387 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
05/18/2010US7718382 Method for identifying compounds for treatment of pain
05/18/2010US7718376 Identification and isolation of somatic stem cells and uses thereof
05/18/2010US7718192 Tamper-resistant oral opioid agonist formulations
05/18/2010CA2465247C Benzimidazoles and analogues and their use as protein kinases inhibitors
05/18/2010CA2439478C Carbamate compounds for use in preventing or treating movement disorders
05/18/2010CA2439475C Carbamate compounds for use in preventing or treating bipolar disorder
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2401498C New self emulsifying drug delivery system
05/18/2010CA2368965C Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
05/18/2010CA2355716C Benzisoxazoles and phenones as .alpha.2-antagonists
05/18/2010CA2304204C Quinoline-containing .alpha.-ketoamide cysteine and serine protease inhibitors
05/18/2010CA2284041C Indolecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
05/18/2010CA2259143C G-beta-gamma regulated phosphatidylinositol-3' kinase p101 regulatory subunit
05/18/2010CA2131797C Condensed indole derivatives as 5ht4-receptor antagonists
05/14/2010WO2010054336A2 Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
05/14/2010WO2010054324A2 Methods for treating clinical conditions associated with lipoprotein lipase activity
05/14/2010WO2010054307A1 Compounds and methods of promoting oligodendrocyte precursor differentiation
05/14/2010WO2010054286A2 Substituted hydroxyphenylamine compounds
05/14/2010WO2010054260A1 Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases
05/14/2010WO2010054253A1 Triazine derivatives as inhibitors of phosphodiesterases
05/14/2010WO2010054126A2 Small molecule modulators of epigenetic regulation and their therapeutic applications
05/14/2010WO2010054078A1 Gamma secretase modulators
05/14/2010WO2010054068A2 Cyclic adenosine monophosphates for reducing the formation of adhesions
05/14/2010WO2010054067A1 Gamma secretase modulators
05/14/2010WO2010054064A1 Gamma secretase modulators
05/14/2010WO2010054024A2 Novel compounds as cannabinoid receptor ligands
05/14/2010WO2010053835A1 Compositions and methods for minimizing or reversing agonist-induced desensitization
05/14/2010WO2010053655A2 Therapeutic methods with withaferin a and analogs
05/14/2010WO2010053471A1 Modulators of atp-binding cassette transporters
05/14/2010WO2010053438A1 Modulators of amyloid beta.
05/14/2010WO2010053435A2 Compounds and methods for the treatment of inflammatory diseases of the cns
05/14/2010WO2010053388A1 New 4,6-disubstituted 2-(4-methylpiperazin-1-yl)pyridine derivatives, a process for their preparation, pharmaceutical composition containing these compounds, their use, a method for modulating monoaminergic receptor activity and a monoaminergic receptor modulating agent
05/14/2010WO2010053182A1 Kynurenine production inhibitor
05/14/2010WO2010053127A1 MODULATOR OF α1GABAA RECEPTOR OR α5GABAA RECEPTOR
05/14/2010WO2010053120A1 Carbamate compound or salt thereof
05/14/2010WO2010052670A1 PROCESS TO PREPARE NEW SUBSTITUTED 1H-BENZO [d] IMIDAZOL-2(3H)-ONES, NEW INTERMEDIATES AND THEIR USE AS BACE 1 INHIBITORS
05/14/2010WO2010052222A1 (dihydro)naphthyridinone derivatives as histamine h3 receptor antagonists
05/14/2010WO2010052198A1 ( pyrrolidin-2 -yl) phenyl derivatives for use in the treatment of pain
05/14/2010WO2010052027A1 Combinational therapy comprising dhodh inhibitor and methotrexate for treating autoimmune disease
05/14/2010WO2010051819A1 Novel 2,3-diamino-quinazolinone derivatives and their medical use
05/14/2010WO2010033292A9 Method for medical treatment utilizing l-glutathione
05/14/2010WO2010033222A3 Polymer conjugates of ziconotide peptides
05/14/2010WO2010017343A3 Flupirtine hydrochloride maleic acid cocrystal
05/14/2010WO2010017093A3 Dopamine receptor ligands with enhanced duration of action
05/14/2010WO2010014739A3 Heterocyclic modulators of tgr5
05/14/2010WO2010008528A3 Marek's disease virus vaccine compositions and methods of using thereof
05/14/2010WO2010005572A3 Alpha-keto heterocycles as faah inhibitors
05/14/2010WO2010004003A3 Modified peptides as potent inhibitors of the psd-95/nmda receptor interaction
05/14/2010WO2009156991A3 Glycerophospholipids for the improvement of cognitive functions
05/14/2010WO2009156678A3 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
05/14/2010WO2009155301A3 Multipotent neural cells
05/14/2010WO2009145814A9 Pyrimidines and pyridines useful as inhibitors of protein kinases
05/14/2010CA2778961A1 Compounds and methods for the treatment of inflammatory diseases of the cns
1 ... 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 ... 1833